Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1)
Bile Duct Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Drugs, Investigational (Phase 1)
Gallbladder Neoplasms (Phase 2)
Hodgkin Disease (Phase 1)
Intraocular Lymphoma (Phase 1)
Leukemia (Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Liver Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Sarcoma, Clear Cell (Phase 1/Phase 2)
Sarcoma, Myeloid (Phase 2)
Sezary Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Testicular Neoplasms (Phase 1)
Waldenstrom Macroglobulinemia (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue